| MeSH term | MeSH ID | Detail |
|---|---|---|
| Reperfusion Injury | D015427 | 65 associated lipids |
| Carcinoma, Ductal, Breast | D018270 | 19 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
Tangeretin
Tangeretin is a lipid of Polyketides (PK) class. Tangeretin is associated with abnormalities such as Cardiovascular Diseases, Complex Regional Pain Syndromes, Blood Clot, Hypercholesterolemia and Restenosis. The involved functions are known as Thrombus, Platelet function, Localized desquamation, Platelet Activation and Signal. Tangeretin often locates in Protoplasm, Cytoplasmic Granules, Cytoplasmic matrix, Plasma membrane and Blood. The associated genes with Tangeretin are GP6 gene, CDK2 gene, CDK6 gene, Tumor Suppressor Genes and CDH1 gene. The related lipids are Lipopolysaccharides. The related experimental models are Mouse Model and Transgenic Model.
Cross Reference
Introduction
To understand associated biological information of Tangeretin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Tangeretin?
Tangeretin is suspected in Complex Regional Pain Syndromes, Cardiovascular Diseases, Blood Clot, Hypercholesterolemia, Restenosis and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Tangeretin
PubChem Associated disorders and diseases
What pathways are associated with Tangeretin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Tangeretin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Semin. Cancer Biol. (1)
- Am. J. Physiol., Cell Physiol. (1)
- Arterioscler. Thromb. Vasc. Biol. (1)
- Others (3)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Tangeretin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Tangeretin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Tangeretin?
Related references are published most in these journals:
- Semin. Cancer Biol. (1)
- Am. J. Physiol., Cell Physiol. (1)
- Arterioscler. Thromb. Vasc. Biol. (1)
- Others (3)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Tangeretin?
Mouse Model
Mouse Model are used in the study 'Methoxyflavones protect cells against endoplasmic reticulum stress and neurotoxin.' (Takano K et al., 2007) and Mouse Model are used in the study 'Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer.' (Bracke ME et al., 1999).
Transgenic Model
Transgenic Model are used in the study 'Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass?' (Walle T, 2007).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Tangeretin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Rong H et al. | 8-Prenylnaringenin, the phytoestrogen in hops and beer, upregulates the function of the E-cadherin/catenin complex in human mammary carcinoma cells. | 2001 | Eur. J. Cell Biol. | pmid:11675933 |
| Depypere HT et al. | Inhibition of tamoxifen's therapeutic benefit by tangeretin in mammary cancer. | 2000 | Eur. J. Cancer | pmid:11056327 |
| Hagenlocher Y et al. | Citrus peel polymethoxyflavones nobiletin and tangeretin suppress LPS- and IgE-mediated activation of human intestinal mast cells. | 2017 | Eur J Nutr | pmid:27021766 |
| Vila-Real H et al. | Enzymatic Synthesis of the Flavone Glucosides, Prunin and Isoquercetin, and the Aglycones, Naringenin and Quercetin, with Selective α-L-Rhamnosidase and β-D-Glucosidase Activities of Naringinase. | 2011 | Enzyme Res | pmid:21941631 |
| Soars MG et al. | An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes. | 2004 | Drug Metab. Dispos. | pmid:14709631 |
| Walle UK and Walle T | Bioavailable flavonoids: cytochrome P450-mediated metabolism of methoxyflavones. | 2007 | Drug Metab. Dispos. | pmid:17709371 |
| Williams JA et al. | Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. | 2002 | Drug Metab. Dispos. | pmid:12386134 |
| Walsky RL et al. | Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors. | 2012 | Drug Metab. Dispos. | pmid:22357286 |
| Mulvihill EE et al. | Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance. | 2011 | Diabetes | pmid:21471511 |
| Bracke ME et al. | The E-cadherin/catenin complex in invasion and metastasis. | 1996 | Curr. Top. Microbiol. Immunol. | pmid:8814984 |
| Malemud CJ | Inhibitors of stress-activated protein/mitogen-activated protein kinase pathways. | 2007 | Curr Opin Pharmacol | pmid:17398158 |
| Mareel MM and De Mets M | Anti-invasive activities of experimental chemotherapeutic agents. | 1989 | Crit. Rev. Oncol. Hematol. | pmid:2686699 |
| Braidy N et al. | Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease. | 2017 | CNS Neurol Disord Drug Targets | pmid:28474543 |
| Backman JT et al. | Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation. | 2000 | Clin. Pharmacol. Ther. | pmid:10801247 |
| Bracke M et al. | Effect of catechins and citrus flavonoids on invasion in vitro. | 1991 Jan-Feb | Clin. Exp. Metastasis | pmid:1901781 |
| Bracke ME et al. | The flavonoid tangeretin inhibits invasion of MO4 mouse cells into embryonic chick heart in vitro. | 1989 May-Jun | Clin. Exp. Metastasis | pmid:2924447 |
| Liu L et al. | Phytochemical analysis of anti-atherogenic constituents of Xue-Fu-Zhu-Yu-Tang using HPLC-DAD-ESI-MS. | 2004 | Chem. Pharm. Bull. | pmid:15516749 |
| Le Bon AM et al. | Inhibition of microsome-mediated binding of benzo[a]pyrene to DNA by flavonoids either in vitro or after dietary administration to rats. | 1992 | Chem. Biol. Interact. | pmid:1643669 |
| Arab HH et al. | Tangeretin attenuates cisplatin-induced renal injury in rats: Impact on the inflammatory cascade and oxidative perturbations. | 2016 | Chem. Biol. Interact. | pmid:27616468 |
| Wang J et al. | Pro-apoptotic effects of the novel tangeretin derivate 5-acetyl-6,7,8,4'-tetramethylnortangeretin on MCF-7 breast cancer cells. | 2014 | Cell Biochem. Biophys. | pmid:24938898 |
| Chaumontet C et al. | Apigenin and tangeretin enhance gap junctional intercellular communication in rat liver epithelial cells. | 1994 | Carcinogenesis | pmid:7955073 |
| Pan MH et al. | Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. | 2002 | Carcinogenesis | pmid:12376477 |
| Arafa el-SA et al. | Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. | 2009 | Cancer Res. | pmid:19903849 |
| Weng CJ and Yen GC | Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. | 2012 | Cancer Metastasis Rev. | pmid:22314287 |
| Chaumontet C et al. | Flavonoids (apigenin, tangeretin) counteract tumor promoter-induced inhibition of intercellular communication of rat liver epithelial cells. | 1997 | Cancer Lett. | pmid:9103293 |
| Kandaswami C et al. | Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. | 1991 | Cancer Lett. | pmid:1998943 |
| Ikegawa T et al. | Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. | 2000 | Cancer Lett. | pmid:11098080 |
| Morley KL et al. | Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. | 2007 | Cancer Lett. | pmid:17197076 |
| Ishii K et al. | Effects of naturally occurring polymethyoxyflavonoids on cell growth, p-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cells. | 2010 | Cancer Invest. | pmid:19863351 |
| Periyasamy K et al. | Antitumor efficacy of tangeretin by targeting the oxidative stress mediated on 7,12-dimethylbenz(a) anthracene-induced proliferative breast cancer in Sprague-Dawley rats. | 2015 | Cancer Chemother. Pharmacol. | pmid:25431347 |
| Ionta M et al. | Exogenous Cx43 expression decrease cell proliferation rate in rat hepatocarcinoma cells independently of functional gap junction. | 2009 | Cancer Cell Int. | pmid:19678939 |
| Li YR et al. | Tangeretin derivative, 5-acetyloxy-6,7,8,4'-tetramethoxyflavone induces G2/M arrest, apoptosis and autophagy in human non-small cell lung cancer cells in vitro and in vivo. | 2016 | Cancer Biol. Ther. | pmid:26569090 |
| Liu LL et al. | Tangeretin has anti-asthmatic effects via regulating PI3K and Notch signaling and modulating Th1/Th2/Th17 cytokine balance in neonatal asthmatic mice. | 2017 | Braz. J. Med. Biol. Res. | pmid:28746467 |
| Cheng Z et al. | Tangeretin and its metabolite 4'-hydroxytetramethoxyflavone attenuate EGF-stimulated cell cycle progression in hepatocytes; role of inhibition at the level of mTOR/p70S6K. | 2011 | Br. J. Pharmacol. | pmid:21198542 |
| Honda Y et al. | Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux. | 2004 | Br. J. Pharmacol. | pmid:15504753 |
| Hirano T et al. | Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. | 1995 | Br. J. Cancer | pmid:8519648 |
| Asami Y et al. | Use of silkworms for identification of drug candidates having appropriate pharmacokinetics from plant sources. | 2010 | BMC Pharmacol. | pmid:20537191 |
| Kim GS et al. | Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling pathway in 3T3-L1 cells. | 2012 | BMC Complement Altern Med | pmid:22471389 |
| Androutsopoulos VP et al. | Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. | 2009 | BMC Cancer | pmid:19531241 |
| Kuroda Y et al. | Activation of human bitter taste receptors by polymethoxylated flavonoids. | 2016 | Biosci. Biotechnol. Biochem. | pmid:27379685 |
| Johnson EJ et al. | Prioritizing pharmacokinetic drug interaction precipitants in natural products: application to OATP inhibitors in grapefruit juice. | 2017 | Biopharm Drug Dispos | pmid:28032362 |
| Nishimuta H et al. | Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3. | 2007 | Biopharm Drug Dispos | pmid:17876860 |
| Quintin J et al. | Synthesis and biological evaluation of a series of tangeretin-derived chalcones. | 2009 | Bioorg. Med. Chem. Lett. | pmid:19013795 |
| Quintin J et al. | Semisynthesis and antiproliferative evaluation of a series of 3'-aminoflavones. | 2009 | Bioorg. Med. Chem. Lett. | pmid:19457664 |
| Akao Y et al. | Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells. | 2008 | Bioorg. Med. Chem. | pmid:18282757 |
| Oshitari T et al. | B-Ring-modified and/or 5-demethylated nobiletin congeners: inhibitory activity against pro-MMP-9 production. | 2011 | Bioorg. Med. Chem. | pmid:22047798 |
| Ma LL et al. | Tangeretin induces cell cycle arrest and apoptosis through upregulation of PTEN expression in glioma cells. | 2016 | Biomed. Pharmacother. | pmid:27261630 |
| Chen F et al. | Tangeretin inhibits high glucose-induced extracellular matrix accumulation in human glomerular mesangial cells. | 2018 | Biomed. Pharmacother. | pmid:29710524 |
| Green CO et al. | Determination of polymethoxylated flavones in peels of selected Jamaican and Mexican citrus (Citrus spp.) cultivars by high-performance liquid chromatography. | 2007 | Biomed. Chromatogr. | pmid:17080505 |
| Choi SY et al. | Correlation between flavonoid content and the NO production inhibitory activity of peel extracts from various citrus fruits. | 2007 | Biol. Pharm. Bull. | pmid:17409518 |